Decatur Capital Management’s AbbVie ABBV Stock Holding History

Decatur Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-73,029	Closed	-$7.17M	–	53
2020 Q2	$7.17M	Buy	73,029 +6	+0%	+$528	1.9%	11
2020 Q1	$5.56M	Sell	73,023 -18,674	-20%	-$1.59M	1.86%	14
2019 Q4	$8.12M	Sell	91,697 -1,198	-1%	-$99.5K	1.86%	13
2019 Q3	$7.03M	Sell	92,895 -36,025	-28%	-$2.47M	1.74%	16
2019 Q2	$9.38M	Sell	128,920 -2,849	-2%	-$224K	1.76%	18
2019 Q1	$10.6M	Buy	+131,769	New	+$10.8M	2.05%	12

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Decatur Capital Management's ABBV Position: Q3 2020 in Review

Decatur Capital Management sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 73,029 shares — an estimated $7.17M sold.

Decatur Capital Management first reported a position in ABBV in Q1 2019 and held it in 6 quarters. The position peaked at $10.6M in Q1 2019. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

Decatur Capital Management reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
Decatur Capital Management sold 73,029 AbbVie shares in Q3 2020, an estimated $7.17M.
Decatur Capital Management first reported a position in AbbVie in Q1 2019 and held it in 6 quarters.
Decatur Capital Management's AbbVie position peaked at $10.6M in Q1 2019.
2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Decatur Capital Management's 13F filing for Q3 2020, filed 3 Nov 2020.